Russell Investments Group Ltd. Sells 5,948 Shares of Owens & Minor, Inc. (NYSE:OMI)

Russell Investments Group Ltd. reduced its position in shares of Owens & Minor, Inc. (NYSE:OMI – Get Rating) by 6.6% during the fourth quarter, Holdings Channel reports. The firm owned 83,649 shares of the company’s stock after selling 5,948 shares during the period. Russell Investments Group Ltd.’s holdings in Owens & Minor were worth $1,633,000 as of its most recent SEC filing.

Other large investors also recently made changes to their positions in the company. Arizona State Retirement System raised its position in Owens & Minor by 4.0% in the fourth quarter. Arizona State Retirement System now owns 20,439 shares of the company’s stock worth $399,000 after acquiring an additional 791 shares during the period. Commonwealth Equity Services LLC raised its position in shares of Owens & Minor by 25.7% in the fourth quarter. Commonwealth Equity Services LLC now owns 56,772 shares of the company’s stock valued at $1,108,000 after purchasing an additional 11,607 shares during the period. Shell Asset Management Co. raised its position in shares of Owens & Minor by 108.0% in the fourth quarter. Shell Asset Management Co. now owns 21,846 shares of the company’s stock valued at $427,000 after purchasing an additional 11,344 shares during the period. Smith Graham & Co. Investment Advisors LP raised its position in shares of Owens & Minor by 19.4% in the fourth quarter. Smith Graham & Co. Investment Advisors LP now owns 435,827 shares of the company’s stock valued at $8,512,000 after purchasing an additional 70,951 shares during the period. Finally, ProShare Advisors LLC grew its stake in Owens & Minor by 14.8% during the fourth quarter. ProShare Advisors LLC now owns 11,719 shares of the company’s stock valued at $229,000 after acquiring an additional 1,508 shares in the last quarter.

Insider Transactions at Owens & Minor

In other news, SVP Jonathan A. Leon sold 6,000 shares of the business’s stock in a transaction that occurred on Wednesday, March 22nd. The shares were sold at an average price of $13.50, for a total value of $81,000.00. Following the completion of the sale, the senior vice president now directly owns 106,723 shares in the company, valued at approximately $1,440,760.50. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Company insiders own 3.59% of the company’s stock.

Owens & Minor Price Performance

OMI stock opened at $20.30 on Wednesday. The stock has a market cap of $1.55 billion, a PE ratio of -36.25, a P/E/G ratio of 4.00 and a beta of 0.57. The company has a debt-to-equity ratio of 2.56, a current ratio of 1.39 and a quick ratio of 0.60. Owens & Minor, Inc. has a one year low of $11.79 and a one year high of $37.03. The firm has a 50 day simple moving average of $15.50 and a two-hundred day simple moving average of $18.14.

Owens & Minor (NYSE:OMI – Get Rating) last announced its quarterly earnings data on Friday, May 5th. The company reported $0.05 earnings per share for the quarter, topping analysts’ consensus estimates of ($0.09) by $0.14. The firm had revenue of $2.52 billion during the quarter, compared to analyst estimates of $2.40 billion. Owens & Minor had a negative net margin of 0.41% and a positive return on equity of 12.12%. The business’s quarterly revenue was up 4.8% on a year-over-year basis. During the same period in the previous year, the business posted $0.96 EPS. On average, analysts predict that Owens & Minor, Inc. will post 1.36 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Several equities analysts recently commented on OMI shares. Robert W. Baird boosted their price objective on shares of Owens & Minor from $18.00 to $21.00 in a research note on Monday, May 8th. Citigroup reduced their price objective on shares of Owens & Minor from $20.00 to $17.00 and set a “neutral” rating for the company in a research note on Wednesday, March 8th. Credit Suisse Group reduced their price objective on shares of Owens & Minor from $20.00 to $17.00 and set a “neutral” rating for the company in a research note on Tuesday, March 7th. UBS Group boosted their price objective on shares of Owens & Minor from $22.00 to $24.00 in a research note on Monday, May 8th. Finally, StockNews.com started coverage on shares of Owens & Minor in a research note on Thursday, May 18th. They set a “hold” rating for the company. Two equities research analysts have rated the stock with a sell rating and four have assigned a hold rating to the company. Based on data from MarketBeat, the stock has an average rating of “Hold” and an average price target of $18.83.

Owens & Minor Profile

(Get Rating)

Owens & Minor, Inc is a healthcare solutions company, which engages in the product manufacturing and delivery, home health supply, and perioperative services to support care through the hospital and into the home. It operates through the Products and Healthcare Services, and Patient Direct segments. The Products and Healthcare Services segment includes medical distribution, the outsourced logistics and value-added services business, and global products, which manufacture and source medical surgical products through the production and kitting operations.